prostaglandin-f1 and Arthritis

prostaglandin-f1 has been researched along with Arthritis* in 2 studies

Other Studies

2 other study(ies) available for prostaglandin-f1 and Arthritis

ArticleYear
Salsalate exacerbation of chronic renal insufficiency. Relation to inhibition of prostaglandin synthesis.
    Archives of internal medicine, 1987, Volume: 147, Issue:9

    Nonacetylated salicylates have not been reported to cause the hemodynamically mediated acute renal failure associated with nonsteroidal anti-inflammatory drug therapy. A 73-year-old woman with a creatinine clearance of 0.33 mL/s (20 mL/min), hypertension, and arteriosclerotic cardiovascular disease developed reversible renal insufficiency when her dose of salsalate was increased to 4.5 g/d (serum salicylate concentration, 2.22 mmol/L [30.7 mg/dL]). Under close observation the patient was re-treated with lower doses of salsalate while renal function and the urinary excretions of prostaglandins were monitored. The excretion of prostaglandin E2 decreased abruptly while the excretion of 6-keto-prostaglandin F1 alpha decreased more gradually as the dose of salsalate was increased. Renal function appeared to decline in parallel with the decrease in 6-keto-prostaglandin F1 alpha and recovered rapidly after discontinuation of salsalate therapy. Nonacetylated salicylates can cause a hemodynamically mediated acute renal failure in patients at risk for this nephropathy.

    Topics: Acute Kidney Injury; Aged; Arthritis; Dinoprostone; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Humans; Prostaglandins; Prostaglandins E; Prostaglandins F; Salicylates

1987
Prostaglandins: a possible mediator to inhibit hepatic drug metabolism in adjuvant arthritic rats.
    Biochemical medicine and metabolic biology, 1986, Volume: 35, Issue:1

    In the liver of adjuvant arthritic rats perfused with a hemoglobin-free buffer solution, the rate of metabolism of a model drug, 2,6-dichloro-4-nitroanisole, was approximately half that of the control, while the bile flow rate was normal. Granulation tissue extracts and arthritic rat serum had no effect on the activity of CNA metabolism in normal rat liver preparations. In the perfused normal rat liver, the rate of CNA metabolism was inhibited by addition of prostaglandin (PG) E1, PGE2, and PGF2 alpha, respectively, in a final concentration of 0.5 microM. The inhibition by PGE1 was increased in the concentration range from 0.1 to 2.5 microM. The bile flow rate was not affected by the added PGs. However, these PGs had no direct effect on the CNA demethylating activity of the isolated hepatocytes from normal rat liver in a high concentration of 10 microM. Serotonin stimulated slightly CNA metabolism and bile production in the perfused livers by the intermittent infusion, but was without effect in the isolated hepatocytes. Epinephrine and histamine had no significant effect on CNA metabolism in both liver preparations. A similar pattern of the inhibition of CNA metabolism by PGs was reproduced in the normal rat liver perfused with the medium containing the supernatant of the hepatic nonparenchymal cells incubated in the presence of PGE1. The involvement of liver sinusoidal cells as secretory cells in depression of hepatic drug metabolism has been discussed.

    Topics: Alprostadil; Animals; Anisoles; Arthritis; Arthritis, Experimental; Dinoprostone; Epinephrine; Histamine; Liver; Male; Prostaglandins; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred F344; Serotonin

1986